Sperm DNA damage

How relevant is it clinically?

Victor E. Beshay, Orhan Bukulmez

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose of review: The true impact of the current sperm DNA fragmentation testing needs further scrutiny to assess whether clinically meaningful information is conveyed. Recent findings: Various studies have suggested different or no threshold values with assorted tests for the percentage of DNA fragmentation in the ejaculated sperm above which natural conception, fertilization or embryo development and/or clinical pregnancy rates are compromised. Current DNA fragmentation assessment methods provide very little specific information on the nature and severity of the DNA damage detected. Although sperm DNA fragmentation is associated with lower pregnancy rates through natural conception or intrauterine insemination, it does not seem to affect intracytoplasmic sperm injection outcome. Although animal studies demonstrated adverse reproductive effects of sperm DNA fragmentation, any conclusive evidence in humans is yet to be demonstrated. It is not clear whether interventions aimed at enrichment of sperm with decreased DNA fragmentation are effective in preventing the potential adverse effects of sperm DNA fragmentation in humans. Major concern about the use of sperm DNA integrity tests as prognostic parameters is that the direct evaluation of DNA fragmentation in individual sperm fertilizing the oocyte is not possible. Summary: The lack of consensus in defining a clinically relevant standard DNA fragmentation test with a meaningful cut-off level brings challenges in implementing the routine use of sperm DNA integrity assessment in daily practice.

Original languageEnglish (US)
Pages (from-to)172-179
Number of pages8
JournalCurrent Opinion in Obstetrics and Gynecology
Volume24
Issue number3
DOIs
StatePublished - Jun 2012

Fingerprint

DNA Fragmentation
DNA Damage
Spermatozoa
Pregnancy Rate
Intracytoplasmic Sperm Injections
Insemination
DNA
Fertilization
Oocytes
Embryonic Development

Keywords

  • assisted reproductive technologies
  • comet
  • DNA integrity
  • intracytoplasmic sperm injection
  • IVF
  • sperm chromatin structure assay, sperm DNA fragmentation, TUNEL

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Sperm DNA damage : How relevant is it clinically? / Beshay, Victor E.; Bukulmez, Orhan.

In: Current Opinion in Obstetrics and Gynecology, Vol. 24, No. 3, 06.2012, p. 172-179.

Research output: Contribution to journalArticle

@article{30529c370fe3498f9b16b182e2402059,
title = "Sperm DNA damage: How relevant is it clinically?",
abstract = "Purpose of review: The true impact of the current sperm DNA fragmentation testing needs further scrutiny to assess whether clinically meaningful information is conveyed. Recent findings: Various studies have suggested different or no threshold values with assorted tests for the percentage of DNA fragmentation in the ejaculated sperm above which natural conception, fertilization or embryo development and/or clinical pregnancy rates are compromised. Current DNA fragmentation assessment methods provide very little specific information on the nature and severity of the DNA damage detected. Although sperm DNA fragmentation is associated with lower pregnancy rates through natural conception or intrauterine insemination, it does not seem to affect intracytoplasmic sperm injection outcome. Although animal studies demonstrated adverse reproductive effects of sperm DNA fragmentation, any conclusive evidence in humans is yet to be demonstrated. It is not clear whether interventions aimed at enrichment of sperm with decreased DNA fragmentation are effective in preventing the potential adverse effects of sperm DNA fragmentation in humans. Major concern about the use of sperm DNA integrity tests as prognostic parameters is that the direct evaluation of DNA fragmentation in individual sperm fertilizing the oocyte is not possible. Summary: The lack of consensus in defining a clinically relevant standard DNA fragmentation test with a meaningful cut-off level brings challenges in implementing the routine use of sperm DNA integrity assessment in daily practice.",
keywords = "assisted reproductive technologies, comet, DNA integrity, intracytoplasmic sperm injection, IVF, sperm chromatin structure assay, sperm DNA fragmentation, TUNEL",
author = "Beshay, {Victor E.} and Orhan Bukulmez",
year = "2012",
month = "6",
doi = "10.1097/GCO.0b013e32835211b5",
language = "English (US)",
volume = "24",
pages = "172--179",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Sperm DNA damage

T2 - How relevant is it clinically?

AU - Beshay, Victor E.

AU - Bukulmez, Orhan

PY - 2012/6

Y1 - 2012/6

N2 - Purpose of review: The true impact of the current sperm DNA fragmentation testing needs further scrutiny to assess whether clinically meaningful information is conveyed. Recent findings: Various studies have suggested different or no threshold values with assorted tests for the percentage of DNA fragmentation in the ejaculated sperm above which natural conception, fertilization or embryo development and/or clinical pregnancy rates are compromised. Current DNA fragmentation assessment methods provide very little specific information on the nature and severity of the DNA damage detected. Although sperm DNA fragmentation is associated with lower pregnancy rates through natural conception or intrauterine insemination, it does not seem to affect intracytoplasmic sperm injection outcome. Although animal studies demonstrated adverse reproductive effects of sperm DNA fragmentation, any conclusive evidence in humans is yet to be demonstrated. It is not clear whether interventions aimed at enrichment of sperm with decreased DNA fragmentation are effective in preventing the potential adverse effects of sperm DNA fragmentation in humans. Major concern about the use of sperm DNA integrity tests as prognostic parameters is that the direct evaluation of DNA fragmentation in individual sperm fertilizing the oocyte is not possible. Summary: The lack of consensus in defining a clinically relevant standard DNA fragmentation test with a meaningful cut-off level brings challenges in implementing the routine use of sperm DNA integrity assessment in daily practice.

AB - Purpose of review: The true impact of the current sperm DNA fragmentation testing needs further scrutiny to assess whether clinically meaningful information is conveyed. Recent findings: Various studies have suggested different or no threshold values with assorted tests for the percentage of DNA fragmentation in the ejaculated sperm above which natural conception, fertilization or embryo development and/or clinical pregnancy rates are compromised. Current DNA fragmentation assessment methods provide very little specific information on the nature and severity of the DNA damage detected. Although sperm DNA fragmentation is associated with lower pregnancy rates through natural conception or intrauterine insemination, it does not seem to affect intracytoplasmic sperm injection outcome. Although animal studies demonstrated adverse reproductive effects of sperm DNA fragmentation, any conclusive evidence in humans is yet to be demonstrated. It is not clear whether interventions aimed at enrichment of sperm with decreased DNA fragmentation are effective in preventing the potential adverse effects of sperm DNA fragmentation in humans. Major concern about the use of sperm DNA integrity tests as prognostic parameters is that the direct evaluation of DNA fragmentation in individual sperm fertilizing the oocyte is not possible. Summary: The lack of consensus in defining a clinically relevant standard DNA fragmentation test with a meaningful cut-off level brings challenges in implementing the routine use of sperm DNA integrity assessment in daily practice.

KW - assisted reproductive technologies

KW - comet

KW - DNA integrity

KW - intracytoplasmic sperm injection

KW - IVF

KW - sperm chromatin structure assay, sperm DNA fragmentation, TUNEL

UR - http://www.scopus.com/inward/record.url?scp=84861064817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861064817&partnerID=8YFLogxK

U2 - 10.1097/GCO.0b013e32835211b5

DO - 10.1097/GCO.0b013e32835211b5

M3 - Article

VL - 24

SP - 172

EP - 179

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - 3

ER -